Hct Dexcel (Hydrochlorothiazide)

Hct Dexcel is prescribed for conditions where reduction of excess fluid or control of elevated blood pressure is required.

• Management of essential hypertension.
• Treatment of edema associated with heart failure.
• Reduction of fluid accumulation in renal disease.
• Relief of ascites related to liver cirrhosis.
• Adjunct therapy for resistant hypertension when combined with other antihypertensive agents.
• Prevention of fluid retention in patients receiving systemic corticosteroids.

Side effects of Hct Dexcel vary in frequency and severity.

Common

• Dizziness or light‑headedness.
• Headache.
• Increased frequency of urination.
• Low potassium (hypokalemia) or other electrolyte disturbances.
• Muscle cramps or weakness.
• Fatigue.

Serious

• Severe dehydration or electrolyte imbalance.
• Allergic reactions such as rash, itching, or angioedema.
• Marked drop in blood pressure (hypotension).
• Acute kidney injury or worsening renal function.
• Blood disorders such as leukopenia or thrombocytopenia.
• Severe gout attacks due to elevated uric acid.

Before starting Hct Dexcel, several safety considerations should be reviewed.

• Evaluate renal function and baseline electrolytes.
• Monitor serum potassium and sodium regularly, especially in the elderly.
• Use with caution in patients with diabetes, as blood glucose may be affected.
• Avoid in severe hepatic impairment where fluid balance is compromised.
• Pregnancy category is unknown; discuss risks with a healthcare professional.
• Patients with a history of gout should be monitored for increased uric acid levels.
• Do not discontinue abruptly; taper under medical supervision if needed.

Hct Dexcel can interact with other medicines, requiring attention to avoid adverse outcomes.

Avoid

• Lithium, due to increased risk of lithium toxicity.
• Concurrent use of other thiazide or loop diuretics that may cause excessive volume loss.
• High‑dose NSAIDs, which can reduce diuretic efficacy and impair renal function.

Use with caution

• ACE inhibitors or ARBs, as combined therapy may increase potassium loss.
• Digoxin, because electrolyte shifts can predispose to arrhythmias.
• Antidiabetic agents, since blood glucose may drop.
• Corticosteroids, which can enhance fluid and electrolyte depletion.
• Antihypertensive agents, to prevent additive hypotensive effects.